Cargando…
Truncated mutants of beta-glucosidase 2 (GBA2) are localized in the mitochondrial matrix and cause mitochondrial fragmentation
The enzyme β-glucosidase 2 (GBA2) is clinically relevant because it is targeted by the drug miglustat (Zavesca(®)) and because it is involved in inherited diseases. Mutations in the GBA2 gene are associated with two neurological diseases on the ataxia-spasticity spectrum, hereditary spastic parapleg...
Autores principales: | Sultana, Saki, Stewart, Jacklyn, van der Spoel, Aarnoud C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269613/ https://www.ncbi.nlm.nih.gov/pubmed/32492073 http://dx.doi.org/10.1371/journal.pone.0233856 |
Ejemplares similares
-
Accumulation of Glucosylceramide in the Absence of the Beta-Glucosidase GBA2 Alters Cytoskeletal Dynamics
por: Raju, Diana, et al.
Publicado: (2015) -
GBA2-Encoded β-Glucosidase Activity Is Involved in the Inflammatory Response to Pseudomonas aeruginosa
por: Loberto, Nicoletta, et al.
Publicado: (2014) -
Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations
por: Li, Hongyu, et al.
Publicado: (2018) -
Bacterial β-Glucosidase Reveals the Structural
and Functional Basis of Genetic Defects in Human Glucocerebrosidase
2 (GBA2)
por: Charoenwattanasatien, Ratana, et al.
Publicado: (2016) -
GBA mutation promotes early mitochondrial dysfunction in 3D neurosphere models
por: Morén, Constanza, et al.
Publicado: (2019)